Roger Paredes
Germans Trias i Pujol Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Roger Paredes as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:56 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05121740 · Extension Study in a Cohort of Adult Patients With COVID-19 InfectionPharmaMar · completed · COVID-19 Infection · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:56 UTC. The ranking covers the 200 most relevant of 67 PubMed records, and a shared surname and initials can bring in a namesake. All 67 on PubMed
- Remdesivir for the Treatment of Covid-19 - Final Report.N Engl J Med · 20205,332 citationsRCR 287.3
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.N Engl J Med · 2022996 citationsRCR 74.3
- A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.N Engl J Med · 2021351 citationsRCR 17.1
- Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.Lancet Infect Dis · 2011337 citationsRCR 10.8
- 300 citationsRCR 10.0
- Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.J Acquir Immune Defic Syndr · 2000180 citationsRCR 6.0
- Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.J Acquir Immune Defic Syndr · 2001142 citationsRCR 3.7
- 138 citationsRCR 3.4
- The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial.Clin Infect Dis · 2015124 citationsRCR 4.9
- 123 citationsRCR 2.5